Nadir Kardiyak Hastalıklarda Kardiyak Pacing ve ICD

Zareba W, Moss AJ, Daubert JP,et al. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol. 2003 Apr;14(4):337-41. doi: 10.1046/j.1540-8167.2003.02545.x.

Goldenberg I, Moss AJ, Peterson DR, et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation. 2008 Apr 29; 117(17):2184-91. doi: 10.1161/CIRCULATIONAHA.107.701243.

Goldenberg I, Moss AJ. Long QT syndrome. J Am Coll Cardiol. 2008 Jun 17. 51(24):2291-300. doi: 10.1016/j.jacc.2008.02.068.

Goldenberg I, Moss AJ, Zareba W, et al. Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. J Cardiovasc Electrophysiol. 2006 Nov; 17(11):1161-8. doi: 10.1111/j.1540-8167.2006.00587.x.

Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018 Oct;15(10):e 323. doi: 10.1016/j.hrthm.2017.10.036.

Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022 Jan 4;24(1):50. doi: 10.1093/europace/euab232.

Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018 Oct;15(10):e73-e189. doi: 10.1016/j.hrthm.2017.10.036.

D'souza RS, Mestroni L, Taylor MRG. Danon disease for the cardiologist: case report and review of the literature. J Community Hosp Intern Med Perspect. 2017 Mar;7 (2):107-114. doi: 10.1080/20009666.2017.1324239.

Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003 Feb;138(4):338. doi: 10.7326/0003-4819-138-4-200302180-00014

Yousef Z, Elliott PM, Cecchi F, et al. Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis. Eur Heart J. 2013 Mar;34(11):802-8. doi: 10.1093/eurheartj/ehs166

AU Patel MR, Cecchi F, Cizmarik, et al. Cardiovascular events in patients with fabry disease natural history data from the fabry registry. J Am Coll Cardiol. 2011 Mar;57(9):1093-9. Doi: 10.1016/j.jacc.2010.11.018.

AU Shah JS, Hughes DA, Sachdev B, et al. Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease. Am J Cardiol. 2005 Sep;96(6):842. doi: 10.1016/j.amjcard.2005.05.033.

Arbustini E, Pilotto A, Repetto A, et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 2002 Mar;39(6):981-990. doi: 10.1016/s0735-1097(02)01724-2.

Feingold B, Mahle WT, Auerbach S, et al. Management of cardiac involvement associated with neuromuscular diseases: a Scientific Statement from the American Heart Association. Circulation 2017 Sep;136(13):e200-e231. doi: 10.1161/CIR.0000000000000526.

Hasselberg NE, Haland TF, Saberniak J, et al. Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J 2018 Mar;39(10):853-860. doi: 10.1093/eurheartj/ehx596.

Anselme F, Moubarak G, Savoure A, et al. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders. Heart Rhythm 2013 Oct;10(10):1492-1498. doi: 10.1016/j.hrthm.2013.06.020.

Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022 Jan 4;24(1):51. doi: 10.1093/europace/euab232.

Wahbi K, Ben Yaou R, Gandjbakhch E, et al. Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies. Circulation 2019 Jul;140(4):293-302. doi: 10.1161/CIRCULATIONAHA.118.039410.

Kabunga P, Lau AK, Phan K, et al. Systematic review of cardiac electrical disease in KearnsSayre syndrome and mitochondrial cytopathy. Int J Cardiol 2015 Feb;181:303-310. doi: 10.1016/j.ijcard.2014.12.038.

Zareba W, Moss AJ, Daubert JP,et al. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol. 2003 Apr;14(4):337-41. doi: 10.1046/j.1540-8167.2003.02545.x.

Goldenberg I, Moss AJ, Peterson DR, et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation. 2008 Apr 29; 117(17):2184-91. doi: 10.1161/CIRCULATIONAHA.107.701243.

Goldenberg I, Moss AJ. Long QT syndrome. J Am Coll Cardiol. 2008 Jun 17. 51(24):2291-300. doi: 10.1016/j.jacc.2008.02.068.

Goldenberg I, Moss AJ, Zareba W, et al. Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. J Cardiovasc Electrophysiol. 2006 Nov; 17(11):1161-8. doi: 10.1111/j.1540-8167.2006.00587.x.

Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018 Oct;15(10):e 323. doi: 10.1016/j.hrthm.2017.10.036.

Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022 Jan 4;24(1):50. doi: 10.1093/europace/euab232.

Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018 Oct;15(10):e73-e189. doi: 10.1016/j.hrthm.2017.10.036.

D'souza RS, Mestroni L, Taylor MRG. Danon disease for the cardiologist: case report and review of the literature. J Community Hosp Intern Med Perspect. 2017 Mar;7 (2):107-114. doi: 10.1080/20009666.2017.1324239.

Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003 Feb;138(4):338. doi: 10.7326/0003-4819-138-4-200302180-00014

Yousef Z, Elliott PM, Cecchi F, et al. Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis. Eur Heart J. 2013 Mar;34(11):802-8. doi: 10.1093/eurheartj/ehs166

AU Patel MR, Cecchi F, Cizmarik, et al. Cardiovascular events in patients with fabry disease natural history data from the fabry registry. J Am Coll Cardiol. 2011 Mar;57(9):1093-9. Doi: 10.1016/j.jacc.2010.11.018.

AU Shah JS, Hughes DA, Sachdev B, et al. Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease. Am J Cardiol. 2005 Sep;96(6):842. doi: 10.1016/j.amjcard.2005.05.033.

Arbustini E, Pilotto A, Repetto A, et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 2002 Mar;39(6):981-990. doi: 10.1016/s0735-1097(02)01724-2.

Feingold B, Mahle WT, Auerbach S, et al. Management of cardiac involvement associated with neuromuscular diseases: a Scientific Statement from the American Heart Association. Circulation 2017 Sep;136(13):e200-e231. doi: 10.1161/CIR.0000000000000526.

Hasselberg NE, Haland TF, Saberniak J, et al. Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J 2018 Mar;39(10):853-860. doi: 10.1093/eurheartj/ehx596.

Anselme F, Moubarak G, Savoure A, et al. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders. Heart Rhythm 2013 Oct;10(10):1492-1498. doi: 10.1016/j.hrthm.2013.06.020.

Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022 Jan 4;24(1):51. doi: 10.1093/europace/euab232.

Wahbi K, Ben Yaou R, Gandjbakhch E, et al. Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies. Circulation 2019 Jul;140(4):293-302. doi: 10.1161/CIRCULATIONAHA.118.039410.

Kabunga P, Lau AK, Phan K, et al. Systematic review of cardiac electrical disease in KearnsSayre syndrome and mitochondrial cytopathy. Int J Cardiol 2015 Feb;181:303-310. doi: 10.1016/j.ijcard.2014.12.038.